BackBiomarin Pharmaceutical - Registered Shares Overview
Biomarin Pharmaceutical Inc. - Registered Shares

Biomarin Pharmaceutical - Registered Shares Discounted Cash Flow

DCF Analysis for BMRN.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$133.10

Current Fair Value

$133.10
139.2% Upside

Undervalued by 139.2% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading